Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices

Authors

  • Régis Pittier,

    1. Institute for Biomedical Engineering and Department of Materials ETH and University of Zurich, Zurich, Switzerland
    Search for more papers by this author
    • Both authors contributed equally and should be regarded as first authors

  • Fabrice Sauthier,

    1. Institute for Biomedical Engineering and Department of Materials ETH and University of Zurich, Zurich, Switzerland
    Search for more papers by this author
    • Both authors contributed equally and should be regarded as first authors

  • Jeffrey A. Hubbell,

    1. Institute for Biomedical Engineering and Department of Materials ETH and University of Zurich, Zurich, Switzerland
    Current affiliation:
    1. Institute for Biological Engineering and Biotechnology, EPFL, Lausanne, Switzerland
    Search for more papers by this author
  • Heike Hall

    Corresponding author
    1. Institute for Biomedical Engineering and Department of Materials ETH and University of Zurich, Zurich, Switzerland
    • Institute for Biomedical Engineering and Department of Materials ETH and University of Zurich, Zurich, Switzerland
    Search for more papers by this author

Abstract

The deposition of fibrin clots in vivo occurs after injury in the peripheral nervous system and their removal correlates with nerve regeneration. Fibrin clots provide a provisional matrix for invading cells, induce wound healing, and become proteolytically removed by regenerating tissue. Here, neurite extension and in vitro myelination were studied within three-dimensional fibrin matrices that were covalently modified with the sixth Ig-like domain of cell adhesion molecules L1 containing N-terminal transglutaminase substrate sequences (TG-L1Ig6) for covalent incorporation into fibrin matrices. TG-L1Ig6 is a specific receptor for αvβ3-integrin involved in neurite extension of PC12 cells and dorsal root ganglion neurons (DRGs). Neurite extension of PC12 cells depended on interactions between cell surface αvβ3 and RGD-sites provided by TG-L1Ig6. In addition, matrix properties such as fibrin crosslink density and matrix degradation by serine proteases were crucial. No involvement of matrix metalloproteinases was found. DRG neurite extension in native fibrin matrices was retarded as compared to neurite extension within L1Ig6-modified and laminin-1-containing matrices. Moreover, myelinated structures were almost exclusively found in TG-L1Ig6-modified and laminin-1-containing matrices. These results indicate that potential use of three-dimensional matrices in a biomaterials-based healing device to induce and/or help in vivo nerve regeneration requires specific structural and biological signals. © 2004 Wiley Periodicals, Inc. J Neurobiol, 2005

Ancillary